{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:22:26Z","timestamp":1762309346645,"version":"build-2065373602"},"reference-count":110,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["24TPA1299152"],"award-info":[{"award-number":["24TPA1299152"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ccl.2024.12.008","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T21:06:58Z","timestamp":1743368818000},"page":"359-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nonatherosclerotic Cardiovascular Disease in Chronic Kidney Disease"],"prefix":"10.1016","volume":"43","author":[{"given":"Nishigandha","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela","family":"Dobre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4 Suppl 1","key":"10.1016\/j.ccl.2024.12.008_bib1","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2024.01.001","article-title":"US renal data system 2023 annual data report: epidemiology of kidney disease in the United States","volume":"83","author":"Johansen","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.ccl.2024.12.008_bib2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1681\/ASN.2016050562","article-title":"Global cardiovascular and renal outcomes of reduced GFR","volume":"28","author":"Thomas","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"4S","key":"10.1016\/j.ccl.2024.12.008_bib3","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.ccl.2024.12.008_bib4","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: a review from the European renal and cardiovascular medicine Working group of the European renal association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.ccl.2024.12.008_bib5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41371-022-00751-4","article-title":"Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations","volume":"37","author":"Law","year":"2023","journal-title":"J Hum Hypertens"},{"issue":"8","key":"10.1016\/j.ccl.2024.12.008_bib7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41581-022-00576-x","article-title":"Cardiac metabolic remodelling in chronic kidney disease","volume":"18","author":"Patel","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2215\/CJN.02110217","article-title":"FGF23 and left ventricular hypertrophy in children with CKD","volume":"13","author":"Mitsnefes","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","article-title":"The framingham predictive instrument in chronic kidney disease","volume":"50","author":"Weiner","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2024.12.008_bib10","doi-asserted-by":"crossref","first-page":"F729","DOI":"10.1152\/ajprenal.00407.2020","article-title":"Salt-sensitive hypertension in chronic kidney disease: distal tubular mechanisms","volume":"319","author":"Bovee","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.kint.2019.11.021","article-title":"Renal TNFalpha activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease","volume":"97","author":"Furusho","year":"2020","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MNH.0000000000000089","article-title":"Vascular effects of dietary salt","volume":"24","author":"Edwards","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"10.1016\/j.ccl.2024.12.008_bib13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/ndt\/gfaa036","article-title":"Tissue sodium concentrations in chronic kidney disease and dialysis patients by lower leg sodium-23 magnetic resonance imaging","volume":"3","author":"Qirjazi","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.ccl.2024.12.008_bib14","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1681\/ASN.2016060662","article-title":"Skin sodium concentration correlates with left ventricular hypertrophy in CKD","volume":"28","author":"Schneider","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ccl.2024.12.008_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm.1960","article-title":"Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism","volume":"15","author":"Machnik","year":"2009","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ccl.2024.12.008_bib16","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.3390\/ijms24098329","article-title":"Tissue sodium accumulation induces organ inflammation and injury in chronic kidney disease","volume":"24","author":"Ito","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/labinvest.2017.4","article-title":"Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice","volume":"97","author":"Sakata","year":"2017","journal-title":"Lab Invest"},{"issue":"8","key":"10.1016\/j.ccl.2024.12.008_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183281","article-title":"Extracellular overhydration linked with endothelial dysfunction in the context of inflammation in haemodialysis dependent chronic kidney disease","volume":"12","author":"Mitsides","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib19","first-page":"5890","article-title":"The impact of sub-clinical over-hydration on left ventricular mass in peritoneal dialysis patients","volume":"8","author":"Hassan","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2215\/CJN.03610414","article-title":"Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD","volume":"10","author":"Tsai","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ccl.2024.12.008_bib21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"issue":"23","key":"10.1016\/j.ccl.2024.12.008_bib22","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ccl.2024.12.008_bib23","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"19","key":"10.1016\/j.ccl.2024.12.008_bib24","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2024.12.008_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2369-15-197","article-title":"Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients","volume":"15","author":"Buiten","year":"2014","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12882-018-0851-3","article-title":"The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study","volume":"19","author":"Kim","year":"2018","journal-title":"BMC Nephrol"},{"issue":"15","key":"10.1016\/j.ccl.2024.12.008_bib27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/cvr\/cvae164","article-title":"Calciprotein particle counts associate with vascular remodelling in chronic kidney disease","volume":"120","author":"Feenstra","year":"2024","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000491025","article-title":"Serum calcification propensity and fetuin-a: biomarkers of cardiovascular disease in kidney transplant recipients","volume":"48","author":"Bostom","year":"2018","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.ccl.2024.12.008_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013060635","article-title":"Serum calcification propensity predicts all-cause mortality in predialysis CKD","volume":"25","author":"Smith","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.ccl.2024.12.008_bib30","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2215\/CJN.04710419","article-title":"Serum calcification propensity and clinical events in CKD","volume":"14","author":"Bundy","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41581-018-0101-8","article-title":"Evolving concepts in the pathogenesis of uraemic cardiomyopathy","volume":"15","author":"Wang","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.ccl.2024.12.008_bib32","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ccl.2024.12.008_bib33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1681\/ASN.2010080798","article-title":"The inflammasomes in kidney disease","volume":"22","author":"Anders","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib34","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.ajkd.2018.09.012","article-title":"Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in patients with CKD: findings from the CRIC study","volume":"73","author":"Amdur","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.ccl.2024.12.008_bib35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1681\/ASN.2018060609","article-title":"Indoxyl sulfate and p-cresyl sulfate promote vascular calcification and associate with glucose intolerance","volume":"30","author":"Opdebeeck","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ccl.2024.12.008_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126048","article-title":"Free levels of selected organic solutes and cardiovascular morbidity and mortality in hemodialysis patients: results from the retained organic solutes and clinical outcomes (ROSCO) investigators","volume":"10","author":"Shafi","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ccl.2024.12.008_bib37","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","article-title":"Heart failure in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"95","author":"House","year":"2019","journal-title":"Kidney Int"},{"issue":"13","key":"10.1016\/j.ccl.2024.12.008_bib38","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cardfail.2021.10.007","article-title":"Ten-year risk-prediction equations for incident heart failure hospitalizations in chronic kidney disease: findings from the chronic renal insufficiency cohort study and the multi-ethnic study of atherosclerosis","volume":"28","author":"Mehta","year":"2022","journal-title":"J Card Fail"},{"issue":"12","key":"10.1016\/j.ccl.2024.12.008_bib40","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Lofman","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ccl.2024.12.008_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011173","article-title":"Risk factors and outcomes associated with heart failure with preserved and reduced ejection fraction in people with chronic kidney disease","volume":"17","author":"Bansal","year":"2024","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/j.ccl.2024.12.008_bib42","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1681\/ASN.2012020145","article-title":"Associations between kidney function and subclinical cardiac abnormalities in CKD","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCHEARTFAILURE.111.966242","article-title":"Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new chronic kidney disease-epidemiology collaboration group formula","volume":"5","author":"McAlister","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.ccl.2024.12.008_bib44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/j.ajkd.2019.02.013","article-title":"Reduced estimated gfr and cardiac remodeling: a population-based autopsy study","volume":"74","author":"Izumaru","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ehf2.12218","article-title":"Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis","volume":"5","author":"Ferreira","year":"2018","journal-title":"ESC Heart Fail"},{"issue":"13","key":"10.1016\/j.ccl.2024.12.008_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014385","article-title":"Association of cardiac biomarkers with the kansas city cardiomyopathy questionnaire in patients with chronic kidney disease without heart failure","volume":"9","author":"Tummalapalli","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2024.08.009","article-title":"Natriuretic peptides, kidney function, and clinical outcomes in heart failure with preserved ejection fraction","volume":"13","author":"Neuen","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.ccl.2024.12.008_bib49","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.ajkd.2020.09.021","article-title":"Change in cardiac biomarkers and risk of incident heart failure and atrial fibrillation in ckd: the chronic renal insufficiency cohort (CRIC) study","volume":"77","author":"Bansal","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.ccl.2024.12.008_bib50","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/jcm9020404","article-title":"Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?","volume":"9","author":"Eiros","year":"2020","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.ccl.2024.12.008_bib51","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.3390\/jcm12083003","article-title":"Connection between cardiac fibrosis biomarkers and echocardiography parameters in advanced chronic kidney disease patients","volume":"12","author":"Ureche","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ccl.2024.12.008_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/biom13020389","article-title":"Predictive value of collagen biomarkers in advanced chronic kidney disease patients","volume":"13","author":"Ureche","year":"2023","journal-title":"Biomolecules"},{"issue":"30","key":"10.1016\/j.ccl.2024.12.008_bib53","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/eurheartj\/ehae288","article-title":"Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification","volume":"45","author":"Dubin","year":"2024","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jash.2012.01.004","article-title":"Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study","volume":"6","author":"Esquitin","year":"2012","journal-title":"J Am Soc Hypertens"},{"issue":"11","key":"10.1016\/j.ccl.2024.12.008_bib55","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41581-023-00747-4","article-title":"Diagnosis of cardiovascular disease in patients with chronic kidney disease","volume":"19","author":"Zoccali","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.ccl.2024.12.008_bib56","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41591-024-03264-4","article-title":"Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes","volume":"30","author":"Vaduganathan","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mayocp.2022.06.007","article-title":"Real-world experience of angiotensin receptor-neprilysin inhibition in reduced ejection fraction heart failure patients with advanced kidney disease","volume":"98","author":"Chang","year":"2023","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1016\/j.ccl.2024.12.008_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258949","article-title":"Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function","volume":"16","author":"Jonsson Holmdahl","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ejhf.2471","article-title":"Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology","volume":"24","author":"Mullens","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib60","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ejhf.1697","article-title":"Evaluation of kidney function throughout the heart failure trajectory \u2013 a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"41","key":"10.1016\/j.ccl.2024.12.008_bib61","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1093\/eurheartj\/ehac401","article-title":"Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ccl.2024.12.008_bib62","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1093\/ndt\/gfz133","article-title":"Valvular heart disease and calcification in CKD: more common than appreciated","volume":"35","author":"Urena-Torres","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.ccl.2024.12.008_bib63","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006044","article-title":"Prevalence and outcomes of left-sided valvular heart disease associated with chronic kidney disease","volume":"6","author":"Samad","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000529543","article-title":"Aortic stenosis and aortic valve replacement among patients with chronic kidney disease: a narrative review","volume":"13","author":"Rivera","year":"2023","journal-title":"Cardiorenal Med"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib65","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.kint.2019.06.025","article-title":"Chronic kidney disease and valvular heart disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"96","author":"Marwick","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib66","first-page":"441","article-title":"Insights into the use of biomarkers in calcific aortic valve disease","volume":"19","author":"Beckmann","year":"2010","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.ccl.2024.12.008_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.944551","article-title":"Potential biomarkers and immune cell infiltration involved in aortic valve calcification identified through integrated bioinformatics analysis","volume":"13","author":"Lv","year":"2022","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12967-023-04171-x","article-title":"Screening of immune-related secretory proteins linking chronic kidney disease with calcific aortic valve disease based on comprehensive bioinformatics analysis and machine learning","volume":"21","author":"Zhu","year":"2023","journal-title":"J Transl Med"},{"issue":"36","key":"10.1016\/j.ccl.2024.12.008_bib69","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib70","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.ajkd.2023.07.023","article-title":"Kidney function, albuminuria, and risk of incident atrial fibrillation: a systematic review and meta-analysis","volume":"83","author":"Ha","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib71","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ccl.2024.12.008_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167517","article-title":"Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation","volume":"133","author":"Song","year":"2023","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1016\/j.ccl.2024.12.008_bib73","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.119.044059","article-title":"Apixaban versus warfarin in patients with atrial fibrillation and advanced chronic kidney disease","volume":"141","author":"Stanifer","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2024.12.008_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066036","article-title":"Prevalence of ventricular arrhythmia and its associated factors in nondialyzed chronic kidney disease patients","volume":"8","author":"Bonato","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib75","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2215\/CJN.09420818","article-title":"Rates of cardiac rhythm abnormalities in patients with CKD and diabetes","volume":"14","author":"Akoum","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib76","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2020030301","article-title":"Two-week burden of arrhythmias across CKD severity in a large community-based cohort: the ARIC study","volume":"32","author":"Kim","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ccl.2024.12.008_bib77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2019.06.012","article-title":"Arrhythmias in patients on maintenance dialysis: a cross-sectional study","volume":"75","author":"Rantanen","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib78","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.mcna.2009.02.002","article-title":"Towards a new paradigm about hypertensive heart disease","volume":"93","author":"Diez","year":"2009","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1253\/circj.CJ-16-0062","article-title":"From left ventricular hypertrophy to dysfunction and failure","volume":"80","author":"Lazzeroni","year":"2016","journal-title":"Circ J"},{"issue":"84","key":"10.1016\/j.ccl.2024.12.008_bib80","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1046\/j.1523-1755.63.s84.1.x","article-title":"Morphology of the heart and arteries in renal failure","author":"Tyralla","year":"2003","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9149(01)01640-X","article-title":"Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy","volume":"88","author":"Varnava","year":"2001","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.ccl.2024.12.008_bib82","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1111\/jcmm.17052","article-title":"Calcium dysregulation increases right ventricular outflow tract arrhythmogenesis in rabbit model of chronic kidney disease","volume":"25","author":"Huang","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"12","key":"10.1016\/j.ccl.2024.12.008_bib83","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2013121343","article-title":"Pathogenesis of arrhythmias in a model of CKD","volume":"25","author":"Hsueh","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ccl.2024.12.008_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065373","article-title":"Pro-arrhythmic potential of accumulated uremic toxins is mediated via vulnerability of action potential repolarization","volume":"24","author":"van Ham","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib85","article-title":"Uremic retention solute indoxyl sulfate level is associated with prolonged QTc interval in early CKD patients","volume":"10","author":"Tang","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib86","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2006.03.025","article-title":"Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction","volume":"98","author":"Goldenberg","year":"2006","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib87","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamainternmed.2017.8462","article-title":"Long-term outcomes associated with implantable cardioverter defibrillator in adults with chronic kidney disease","volume":"178","author":"Bansal","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.ajkd.2013.12.009","article-title":"Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials","volume":"64","author":"Pun","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.ccl.2024.12.008_bib89","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.kint.2017.11.019","article-title":"Primary outcomes of the monitoring in dialysis study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle","volume":"93","author":"Roy-Chaudhury","year":"2018","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib90","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ndt\/gfab023","article-title":"Asystole episodes and bradycardia in patients with end-stage renal disease","volume":"37","author":"Rautavaara","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.ccl.2024.12.008_bib91","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.hrthm.2015.06.033","article-title":"Temporal distribution of arrhythmic events in chronic kidney disease: Highest incidence in the long interdialytic period","volume":"12","author":"Wong","year":"2015","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib92","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.122.011466","article-title":"Chronic kidney disease induces proarrhythmic remodeling","volume":"16","author":"King","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib93","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2215\/CJN.12131111","article-title":"Expect the unexpected: sudden cardiac death in dialysis patients","volume":"7","author":"Parekh","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ccl.2024.12.008_bib94","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/HYPERTENSIONAHA.110.151167","article-title":"Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis","volume":"56","author":"Wang","year":"2010","journal-title":"Hypertension"},{"issue":"23","key":"10.1016\/j.ccl.2024.12.008_bib95","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2024.12.008_bib96","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2009.219","article-title":"Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease","volume":"76","author":"Pun","year":"2009","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib97","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.hlc.2018.08.026","article-title":"Epidemiology of sudden cardiac death: global and regional perspectives","volume":"28","author":"Wong","year":"2019","journal-title":"Heart Lung Circ"},{"issue":"14","key":"10.1016\/j.ccl.2024.12.008_bib98","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1161\/CIRCULATIONAHA.118.036553","article-title":"Racial differences in sudden cardiac death","volume":"139","author":"Zhao","year":"2019","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ccl.2024.12.008_bib99","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013751","article-title":"Effect of sex and underlying disease on the genetic association of QT interval and sudden cardiac death","volume":"8","author":"Mitchell","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jacc.2018.09.083","article-title":"New concepts in sudden cardiac arrest to address an intractable epidemic: JACC state-of-the-art review","volume":"73","author":"Narayan","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"44","key":"10.1016\/j.ccl.2024.12.008_bib101","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1093\/eurheartj\/ehy474","article-title":"A comprehensive evaluation of the genetic architecture of sudden cardiac arrest","volume":"39","author":"Ashar","year":"2018","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ccl.2024.12.008_bib102","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-158-8-201304160-00004","article-title":"Risk prediction models for patients with chronic kidney disease: a systematic review","volume":"158","author":"Tangri","year":"2013","journal-title":"Annals of internal medicine"},{"issue":"17","key":"10.1016\/j.ccl.2024.12.008_bib103","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2024.12.008_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99891-9","article-title":"Ventricular arrhythmias in mouse models of diabetic kidney disease","volume":"11","author":"Laurita","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ccl.2024.12.008_bib105","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.ccl.2024.12.008_bib106","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"Suppl 15","key":"10.1016\/j.ccl.2024.12.008_bib107","first-page":"S412","article-title":"Management of cardiovascular disease in chronic kidney disease: implications for managed care","volume":"17","author":"Calabrese","year":"2011","journal-title":"Am J Manag Care"},{"issue":"20","key":"10.1016\/j.ccl.2024.12.008_bib108","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Final report of a trial of intensive versus standard blood-pressure control","volume":"384","author":"Group","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2024.12.008_bib109","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.ajkd.2021.09.013","article-title":"KDOQI US commentary on the 2021 KDIGO clinical practice guideline for the management of blood pressure in CKD","volume":"79","author":"Drawz","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.ccl.2024.12.008_bib110","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2022.08.012","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"102","author":"de Boer","year":"2022","journal-title":"Kidney Int"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865124001188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865124001188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:18:59Z","timestamp":1762309139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865124001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":110,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0733865124001188"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2024.12.008","relation":{},"ISSN":["0733-8651"],"issn-type":[{"type":"print","value":"0733-8651"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonatherosclerotic Cardiovascular Disease in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2024.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}